Key terms

About ATOS

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATOS news

Yesterday 12:05pm ET Promising Synergies: Atossa Therapeutics’ Advances in ER+/HER2- Breast Cancer Treatment by TipRanks Yesterday 8:34am ET Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial by TipRanks Apr 03 3:20pm ET Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS) by TipRanks Apr 03 2:01am ET Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance by TipRanks Apr 02 6:26am ET Optimistic Outlook for Atossa Therapeutics’ Z-endoxifen in Breast Density and Cancer Therapy by TipRanks Mar 22 11:33am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 21 9:29am ET Atossa Therapeutics provides five-year (Z)-endoxifen update by TipRanks Mar 19 8:39am ET Atossa Therapeutics provides five-year Z-Endoxifen treatment update by TipRanks Mar 18 8:35am ET Atossa Therapeutics regains compliance with Nasdaq minimum bid price rule by TipRanks Mar 12 8:43am ET Atossa Therapeutics Appoints Dr. Cigler, Expands Board Governance by TipRanks Mar 12 8:43am ET Atossa Therapeutics appoints Tessa Cigler to board of directors by TipRanks Feb 22 8:38am ET Atossa Therapeutics announces first patient dosing of Z-endoxifen by TipRanks Feb 12 6:09am ET Atossa Therapeutics initiated with a Buy at H.C. Wainwright by TipRanks Feb 08 2:16pm ET Atossa Therapeutics: A Promising Contender in Breast Cancer Therapy with Solid Financials by TipRanks Feb 07 8:42am ET Atossa announces full enrollment of Z-endoxifen arm of I-SPY 2 trial by TipRanks

No recent press releases are available for ATOS

ATOS Financials

1-year income & revenue

Key terms

ATOS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATOS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments